AcouSort and BlueCell in commercial planning as the stem cell therapy project Blue4Therapy approaches completion
The Blue4Therapy project was initiated in May 2020 with the ambition to develop clinical applications in cell therapy and stem cell treatments – two areas with great commercial potential. Behind the project are the University of Southern Denmark, BlueCell Therapeutics, Novozymes and AcouSort. AcouSort’s contribution to the project has been to develop a module for the purification of stem cells in a point-of-care environment (POC).
Read the full press release here.
Läs hela pressmeddelandet här.